tirzepatide systematic review vs. Semaglutide for Patients with Obesity: A Head-to-Head Trial https://jwat.ch/3ZijGUc Tirzepatide and autoimmune disease: what

The results follow previous research* from the same international team finding that weekly injections of semaglutide were linked to a 20% reduction in major adverse cardiac events (MACE) such as heart attacks and strokes for people with obesity or who were overweight and had cardiovascular disease

Randomized trials are warranted in the future to further assess the gut mechanism after bariatric surgeries in humans

Mounjaro will not work on its own

Tosin, is a triple board-certified internal medicine, obesity medicine, and lifestyle medicine physician and a Fellow of the American College of Physicians, with over twenty years of clinical experience

My patients have some transient nausea for a day or two, and we treat that with nausea medicines

We offer a quick 5-minute health assessment quiz to help determine if youre a candidate for Hormone Replacement Therapy